Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Februar 2026 07:00 ET | Quelle: Regeneron Pharmaceuticals, Inc.

Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

FOP is an ultra-rare genetic disorder characterized by abnormal bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability If...
18. Februar 2026 08:30 ET | Quelle: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands...
18. Februar 2026 06:47 ET | Quelle: Research and Markets

Longevity Market Report 2026-2036: Advances in AI, Genomics and Regenerative Medicine Are Accelerating Developments

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Longevity Market Report 2026-2036" report has been added to ResearchAndMarkets.com's offering.Overall world revenue for Longevity Market will surpass...
17. Februar 2026 11:32 ET | Quelle: Research and Markets

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031" drug pipelines has been added to ResearchAndMarkets.com's...
17. Februar 2026 08:00 ET | Quelle: MediWound Ltd.

MediWound to Present at Upcoming Investor Conferences

MediWound to Present at Upcoming Investor Conferences YAVNE, Israel, February 17, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair,...
17. Februar 2026 07:28 ET | Quelle: Nutriband Inc.

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

New Strategic Partnership
16. Februar 2026 06:30 ET | Quelle: Research and Markets

India Pharmaceutical Directory 2026: Essential Business Intelligence for Sourcing, Selling and Expanding Across India's Pharma and Biotech Value Chain

Dublin, Feb. 16, 2026 (GLOBE NEWSWIRE) -- The "Indian Pharmaceutical Directory" directory has been added to ResearchAndMarkets.com's offering.The Indian pharmaceutical industry is undergoing...
12. Februar 2026 11:27 ET | Quelle: Research and Markets

3 Day Pharma Mini MBA Training Course: Translate Your Learning Into New Behaviours and Improvements (ONLINE EVENT: Mar 18th - Mar 20th, 2026)

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course (Mar 18th - Mar 20th, 2026)" training has been added to ResearchAndMarkets.com's offering. Working in the...
11. Februar 2026 12:30 ET | Quelle: Sanofi Winthrop Industrie

Sanofi: Informations relatives au nombre de droits de vote et d'actions – JANVIER 2026

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
11. Februar 2026 12:30 ET | Quelle: Sanofi Winthrop Industrie

Sanofi: Information concerning the total number of voting rights and shares – January 2026

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...

Nächste Seite